| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | SVP, Chief Medical Officer | Common Stock | 121,932 | $1,771,671 | $14.53 | 02 Feb 2026 | Direct |
| Aurinia Pharmaceuticals Inc. | SVP, Chief Medical Officer | Employee Stock Option (right to buy) | 95,570 | 28 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Feb 2026 | 1 | -$167,851 | 4 | SVP, Chief Medical Officer | 03 Feb 2026, 16:49 |
| AUPH | Aurinia Pharmaceuticals Inc. | 01 Aug 2025 | 1 | -$210,000 | 4 | Chief Medical Officer | 05 Aug 2025, 16:07 |
| AUPH | Aurinia Pharmaceuticals Inc. | 07 Mar 2025 | 1 | -$68,350 | 4 | Chief Medical Officer | 07 Mar 2025, 17:25 |
| AUPH | Aurinia Pharmaceuticals Inc. | 28 Feb 2025 | 3 | -$97,912 | 4 | Chief Medical Officer | 04 Mar 2025, 20:59 |
| AUPH | Aurinia Pharmaceuticals Inc. | 07 Nov 2024 | 0 | $0 | 3 | Chief Medical Officer | 12 Nov 2024, 19:05 |